Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates
06:00am, Wednesday, 07'th Feb 2024
One mistake investors make when buying dividend stocks is chasing yield. Stocks with the highest yield could be a sign a company is struggling, which could put the yield at risk.
HAE vs. ABT: Which Stock Is the Better Value Option?
12:46pm, Tuesday, 06'th Feb 2024
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Abbott (ABT). But which of these two stocks presents investors with the better value op
2 Stocks to Buy Near Their 52-Week Highs
09:45am, Monday, 05'th Feb 2024
Abbott Laboratories didn't perform well last year, but it still has bright prospects. Netflix reported strong earnings that point to plenty of growth potential ahead.
2 Healthcare Dividend Kings to Buy and Hold Forever
08:20am, Sunday, 04'th Feb 2024
Abbott Laboratories and Johnson & Johnson have increased their payouts annually for 52 and 61 consecutive years, respectively. Both healthcare companies have long track records of important innovation
Abbott Labs must face lawsuit over PediaSure height claims
06:22pm, Friday, 02'nd Feb 2024
A judge has rejected Abbott Laboratories' effort to dismiss a New York City grandmother's lawsuit claiming it misled consumers into believing its PediaSure Grow & Gain nutrition drinks were "clinicall
Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?
05:03am, Friday, 02'nd Feb 2024
Novo Nordisk and Eli Lilly have generated billions of dollars in revenue selling weight loss drugs. Abbott Labs is launching a complementary product for those on the weight loss path.
4 med tech stocks with improving prognosis for 2024
07:20am, Wednesday, 31'st Jan 2024
Med tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of COVID and its effect on procedure volumes were slow to dissipate,
Jim Cramer just bought Abbott stock: should you too?
04:14pm, Monday, 29'th Jan 2024
A near 2.0% post-earnings decline in Abbott Laboratories (NYSE: ABT) warrants an investment in the health care giant, says Jim Cramer. Cramer's bullish view on Abbott stock His Charitable Trust bought
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
10:00am, Monday, 29'th Jan 2024
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Up Just 6% In 2023 Is Medtronic Stock A Better Pick Over Abbott?
08:30am, Monday, 29'th Jan 2024
Given its better prospects, we believe Medtronic stock (NYSE: MDT) is a better pick than its peer, Abbott stock (NYSE: ABT). Abbott trades at a higher valuation multiple of 4.9x revenues vs.
7 ‘AgeTech' Stocks to Profit From the Booming Longevity Market
08:07pm, Sunday, 28'th Jan 2024
While it doesn't seem like it when you're young, aging happens to everyone and therefore, so-called AgeTech stocks should benefit from inevitability. A buzzword for age-related technology, this concep
Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?
10:41am, Friday, 26'th Jan 2024
Here is how Abbott (ABT) and Akoya Biosciences (AKYA) have performed compared to their sector so far this year.
Abbott: Strong R&D Pipeline Continues To Drive Growth; Reiterate 'Strong Buy'
03:21am, Friday, 26'th Jan 2024
Abbott Laboratories' stock price has risen by 16.6% since October 2023, outperforming the index. The company achieved strong growth in FY23, excluding contributions from COVID testing businesses. Abbo
Abbott Laboratories on track for new highs in 2024
10:04am, Thursday, 25'th Jan 2024
Abbott Laboratories NYSE: ABT share price fell following its Q4 2023 results, but investors should be cheering the news. The decline is a response to a report that was largely as expected, with the ex
Once Slowed By Shutdown, Abbott Labs Says Baby Formula Franchise Back Leading U.S. Market
01:57pm, Wednesday, 24'th Jan 2024
Less than two years after a headline-grabbing shutdown of a baby formula plant in Michigan that fueled a national crisis, Abbott Laboratories has “reclaimed its previous market-leading position.”
